Literature DB >> 18482055

Simple, defensible sample sizes based on cost efficiency.

Peter Bacchetti1, Charles E McCulloch, Mark R Segal.   

Abstract

The conventional approach of choosing sample size to provide 80% or greater power ignores the cost implications of different sample size choices. Costs, however, are often impossible for investigators and funders to ignore in actual practice. Here, we propose and justify a new approach for choosing sample size based on cost efficiency, the ratio of a study's projected scientific and/or practical value to its total cost. By showing that a study's projected value exhibits diminishing marginal returns as a function of increasing sample size for a wide variety of definitions of study value, we are able to develop two simple choices that can be defended as more cost efficient than any larger sample size. The first is to choose the sample size that minimizes the average cost per subject. The second is to choose sample size to minimize total cost divided by the square root of sample size. This latter method is theoretically more justifiable for innovative studies, but also performs reasonably well and has some justification in other cases. For example, if projected study value is assumed to be proportional to power at a specific alternative and total cost is a linear function of sample size, then this approach is guaranteed either to produce more than 90% power or to be more cost efficient than any sample size that does. These methods are easy to implement, based on reliable inputs, and well justified, so they should be regarded as acceptable alternatives to current conventional approaches.

Mesh:

Year:  2008        PMID: 18482055      PMCID: PMC2769573          DOI: 10.1111/j.1541-0420.2008.01004_1.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  15 in total

1.  The sample size for a clinical trial: a Bayesian-decision theoretic approach.

Authors:  J Halpern; B W Brown; J Hornberger
Journal:  Stat Med       Date:  2001-03-30       Impact factor: 2.373

2.  A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials.

Authors:  Franklin G Miller; Howard Brody
Journal:  Hastings Cent Rep       Date:  2003 May-Jun       Impact factor: 2.683

3.  Peer review of statistics in medical research. Rationale for requiring power calculations is needed.

Authors:  David F Horrobin
Journal:  BMJ       Date:  2002-08-31

4.  Value of information analysis in environmental health risk management decisions: past, present, and future.

Authors:  Fumie Yokota; Kimberly M Thompson
Journal:  Risk Anal       Date:  2004-06       Impact factor: 4.000

5.  Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trials.

Authors:  A S Detsky
Journal:  Stat Med       Date:  1990 Jan-Feb       Impact factor: 2.373

6.  The value of information and optimal clinical trial design.

Authors:  Andrew R Willan; Eleanor M Pinto
Journal:  Stat Med       Date:  2005-06-30       Impact factor: 2.373

7.  Equipoise and the ethics of clinical research.

Authors:  B Freedman
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

8.  The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results.

Authors:  S N Goodman; J A Berlin
Journal:  Ann Intern Med       Date:  1994-08-01       Impact factor: 25.391

9.  The continuing unethical use of placebo controls.

Authors:  K J Rothman; K B Michels
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

10.  A multiple testing procedure for clinical trials.

Authors:  P C O'Brien; T R Fleming
Journal:  Biometrics       Date:  1979-09       Impact factor: 2.571

View more
  24 in total

1.  Selective genotyping and phenotyping strategies in a complex trait context.

Authors:  Saunak Sen; Frank Johannes; Karl W Broman
Journal:  Genetics       Date:  2009-01-19       Impact factor: 4.562

2.  Small sample size is not the real problem.

Authors:  Peter Bacchetti
Journal:  Nat Rev Neurosci       Date:  2013-07-03       Impact factor: 34.870

3.  Breaking free of sample size dogma to perform innovative translational research.

Authors:  Peter Bacchetti; Steven G Deeks; Joseph M McCune
Journal:  Sci Transl Med       Date:  2011-06-15       Impact factor: 17.956

Review 4.  Current sample size conventions: flaws, harms, and alternatives.

Authors:  Peter Bacchetti
Journal:  BMC Med       Date:  2010-03-22       Impact factor: 8.775

Review 5.  Predictive validity in drug discovery: what it is, why it matters and how to improve it.

Authors:  Jack W Scannell; James Bosley; John A Hickman; Gerard R Dawson; Hubert Truebel; Guilherme S Ferreira; Duncan Richards; J Mark Treherne
Journal:  Nat Rev Drug Discov       Date:  2022-10-04       Impact factor: 112.288

6.  Design of implementation studies for quality improvement programs: an effectiveness-cost-effectiveness framework.

Authors:  Ken Cheung; Naihua Duan
Journal:  Am J Public Health       Date:  2013-11-14       Impact factor: 9.308

7.  Sample size, statistical power, and false conclusions in infant looking-time research.

Authors:  Lisa M Oakes
Journal:  Infancy       Date:  2014-04-05

8.  Power, Ethics and Obligation.

Authors:  Jonathan Adam Gelfond; Elizabeth Heitman; Brad H Pollock; Craig H Klugman
Journal:  Stat Med       Date:  2012-11-23       Impact factor: 2.373

Review 9.  Reporting of sample size calculation in randomised controlled trials: review.

Authors:  Pierre Charles; Bruno Giraudeau; Agnes Dechartres; Gabriel Baron; Philippe Ravaud
Journal:  BMJ       Date:  2009-05-12

10.  Maternal exposure to particulate air pollution and term birth weight: a multi-country evaluation of effect and heterogeneity.

Authors:  Payam Dadvand; Jennifer Parker; Michelle L Bell; Matteo Bonzini; Michael Brauer; Lyndsey A Darrow; Ulrike Gehring; Svetlana V Glinianaia; Nelson Gouveia; Eun-hee Ha; Jong Han Leem; Edith H van den Hooven; Bin Jalaludin; Bill M Jesdale; Johanna Lepeule; Rachel Morello-Frosch; Geoffrey G Morgan; Angela Cecilia Pesatori; Frank H Pierik; Tanja Pless-Mulloli; David Q Rich; Sheela Sathyanarayana; Juhee Seo; Rémy Slama; Matthew Strickland; Lillian Tamburic; Daniel Wartenberg; Mark J Nieuwenhuijsen; Tracey J Woodruff
Journal:  Environ Health Perspect       Date:  2013-02-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.